Privia Health Group Inc (NASDAQ: PRVA)’s stock price has decreased by -2.03 compared to its previous closing price of 19.25. However, the company has seen a 4.60% increase in its stock price over the last five trading sessions. GlobeNewsWire reported 2024-04-09 that ARLINGTON, Va., April 09, 2024 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2024 before market open on Thursday, May 9, 2024.
Is It Worth Investing in Privia Health Group Inc (NASDAQ: PRVA) Right Now?
Privia Health Group Inc (NASDAQ: PRVA) has a higher price-to-earnings ratio of 101.84x compared to its average ratio, The 36-month beta value for PRVA is at 0.83. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for PRVA is 101.96M, and currently, shorts hold a 6.00% of that float. The average trading volume for PRVA on May 09, 2024 was 898.45K shares.
PRVA’s Market Performance
The stock of Privia Health Group Inc (PRVA) has seen a 4.60% increase in the past week, with a -2.68% drop in the past month, and a -4.80% fall in the past quarter. The volatility ratio for the week is 2.90%, and the volatility levels for the past 30 days are at 3.34% for PRVA. The simple moving average for the past 20 days is 2.75% for PRVA’s stock, with a -14.94% simple moving average for the past 200 days.
Analysts’ Opinion of PRVA
Many brokerage firms have already submitted their reports for PRVA stocks, with Citigroup repeating the rating for PRVA by listing it as a “Buy.” The predicted price for PRVA in the upcoming period, according to Citigroup is $25 based on the research report published on April 22, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see PRVA reach a price target of $22. The rating they have provided for PRVA stocks is “Equal Weight” according to the report published on March 06th, 2024.
Jefferies gave a rating of “Buy” to PRVA, setting the target price at $25 in the report published on February 26th of the current year.
PRVA Trading at -3.77% from the 50-Day Moving Average
After a stumble in the market that brought PRVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.45% of loss for the given period.
Volatility was left at 3.34%, however, over the last 30 days, the volatility rate increased by 2.90%, as shares surge +1.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.08% lower at present.
During the last 5 trading sessions, PRVA rose by +4.60%, which changed the moving average for the period of 200-days by -29.97% in comparison to the 20-day moving average, which settled at $18.37. In addition, Privia Health Group Inc saw -18.11% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PRVA starting from Mehrotra Parth, who sale 12,219 shares at the price of $18.42 back on Apr 30 ’24. After this action, Mehrotra Parth now owns 261,640 shares of Privia Health Group Inc, valued at $225,074 using the latest closing price.
Morris Matthew Shawn, the Director of Privia Health Group Inc, sale 11,059 shares at $18.42 during a trade that took place back on Apr 30 ’24, which means that Morris Matthew Shawn is holding 70,101 shares at $203,707 based on the most recent closing price.
Stock Fundamentals for PRVA
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.1 for the gross margin
The net margin for Privia Health Group Inc stands at 0.01. The total capital return value is set at 0.03. Equity return is now at value 4.35, with 2.55 for asset returns.
Based on Privia Health Group Inc (PRVA), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 10.13. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -0.01.
Currently, EBITDA for the company is 27.18 million with net debt to EBITDA at -14.02. When we switch over and look at the enterprise to sales, we see a ratio of 1.12. The receivables turnover for the company is 5.7for trailing twelve months and the total asset turnover is 1.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.81.
Conclusion
In conclusion, Privia Health Group Inc (PRVA) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
